Novel Radical Cyclization of N-Aziridinyl Imines

DOI: 10.1021/ja00026a041

Source and publish data:

Journal of the American Chemical Society p. 9882 - 9883 (1991)

Update date:2022-08-03

Topics:

Authors:

Kim, Sunggak

Kee, In Seo

Lee, Sangphil

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00026a041

Full text of DOI:10.1021/ja00026a041

Products guided by the article

Product name:2-{2-[(Z)-2-Phenyl-aziridin-1-ylimino]-propyl}-2-prop-2-ynyl-malonic acid diethyl ester

Cas No:137435-41-7

R&D Labs maybe for 137435-41-7

Tractus Company Limited

Contact:+852-8198 2399

Address:9E, Leapont Industrial Building, 18-28 Wo Liu Hang Road, Shatin, New Territories, Hong Kong
Shanghai Yuantai Chemical Products Co., Ltd

Contact:021--66129803

Address:Chengyin Road,Shanghai,China
JiYi Chemical (Beijing) Co., Ltd.

Contact:+86-10-89385733

Address:Shilou Town of Fangshan District， Beijing
chemonlinephramacistdepot

Contact:86-607-68073220

Address:1 ave na road jiahua st
Xinchang Yueding Chemical Co., Ltd.

Contact:86-571-56926323

Address:NO.90 BEIMENCHENGWAI CHENGGUAN TOWN XINCHANG

Relevant to this article

N-propylbenzoguanamine sulfonic acid-functionalized magnetic nanoparticles: A novel and magnetically retrievable catalyst for the synthesis of 1,4-dihydropyridine derivatives

Doi:10.1002/jccs.201800120
(2018)
New saccharin derivatives as tyrosinase inhibitors

Doi:10.1016/j.bmc.2012.03.033
(2012)
Structure-activity relationships of 2′,5′-oligoadenylate analogue modifications of prostate-specific membrane antigen (PSMA) antagonists

Doi:10.1080/15257770.2012.671988
(2012)
Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model

Doi:10.1016/j.bmcl.2012.07.077
(2012)
Concise enantio- and diastereoselective total syntheses of fumagillol, RK-805, FR65814, ovalicin, and 5-demethylovalicin

Doi:10.1002/anie.200502826
(2006)
Discovery of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors with Antitumor Activity

Doi:10.1021/acsmedchemlett.8b00631
(2019)

Article Doi